ArticlePloS one2025
Evaluation and screening of peanut (Arachis hypogaea L.) germplasm for nutritional and biochemical enhancement with in-vitro assessment of anti-cancer properties.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The risk of HIV and HCV transmission in Canadians living with coinfection before, during, and after the COVID pandemic: A prospective cohort study.Canadian journal of public health = Revue canadienne de sante publique · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peanut breeding increasingly emphasizes nutritional enhancement and bioactive potential to support functional food development. This study assessed twenty-eight peanut genotypes for compositional diversity and invitro anticancer and attributes.Principal component analysis revealed 47.78% of the total variation among genotypes, primarily influenced by protein,oleic acid and phenolic content. Significant variation was observed in fatty acid and phenolic profiles revealing genotypes with superior nutritional and antioxidant properties. High phenolics and antioxidant rich genotypes were further analyzed using invitro assay (Resazurin-red) suggesting possible anticancer effects. LC/MS profiling identified 11 phenolic compounds such as p-coumaric acid and quercetin, associated with antioxidant and chemopreventive effects. Extract from the most bioactive genotypes effectively reduced colon cancer cell viability, suggesting possible anticancer potential. All the genotypes have maintained aflatoxin levels below safety thresholds, confirming their suitability for food use. Overall the findings highlight the potential of nutritionally enhanced peanut germplasm for developing dual purpose varieties with improved health and dietary benefits. These results provide a valuable foundation for breeding programs targeting functional and chemopreventive peanut cultivars. However, further in vivo validation of phenolic-driven anticancer mechanisms is warranted to advance functional peanut varieties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.